Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 2Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 64Other hematologic neoplasm 57Myeloid 26Classical hematology 17Sarcoma 16Plasma cell 15Genitourinary 8Dermatologic 8CNS 7Gynecologic 5Breast 4Other neoplasm 2Gastrointestinal 2Thoracic 1Head & Neck 1

Conditions

Thymoma 1Myelodysplastic Syndromes 1Leukemia 1Graft vs Host Disease 1Anemia, Refractory 1

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Methylprednisolone × Thoracic × Clear all
NCT00003662 2011-03-07

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases

Roswell Park Cancer Institute

Phase 2 Completed
90 enrolled
Classical hematologyMyeloidOther hematologic neoplasmThoracic

Anemia, Refractory, Graft vs Host Disease, Leukemia, Myelodysplastic Syndromes, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡